New Publication: Structure of MmpL3 Philip Fowler, 21st July 202121st July 2021 Oliver Adams successfully elucidated the structure of the M. tuberculosis MmpL3 membrane transporter using cryo-EM and this has recently been published online in Structure. This was the main aim of his PhD studies in Simon Newstead‘s group in the Department of Biochemistry here in Oxford. It is an important protein structure since although other MmpL3 structures have been solved, this is the first one from M. tuberculosis and, as the only essential member of the MmpL family, is targeted by a number of drugs under development, for example SQ109 which is currently in Phase 2 clinical trials. Being able to see how the drug interacts with the protein can help us understand a variety of effects, from binding to resistance. Share this:TwitterBlueskyEmailLinkedInMastodon Related antimicrobial resistance publication research tuberculosis
clinical microbiology New publication: Antibody Status and Incidence of SARS-CoV-2 Infection in Health Care Workers 13th January 202113th January 2021 A second Covid-19 publication I’m proud to be (a small) part of has recently published… Share this:TwitterBlueskyEmailLinkedInMastodon Read More
antimicrobial resistance Updated preprint: predicting pyrazinamide resistance 21st November 20238th December 2023 This study was performed by Josh Carter back in 2019 and we uploaded a preprint… Share this:TwitterBlueskyEmailLinkedInMastodon Read More
antimicrobial resistance New preprint: Predicting pyrazinamide resistance by machine learning 29th April 201929th April 2019 Usually, the protein that an antibiotic binds is essential for bacterial survival, which is how… Share this:TwitterBlueskyEmailLinkedInMastodon Read More